Topiramate-Induced Restless Leg Syndrome

Diagnosis and Management

• The American Academy of Sleep Medicine does not include topiramate in current evidence-based treatment guidelines for restless leg syndrome, due to its potential to induce or worsen the condition 1, 3
• Discontinuation of topiramate is the primary intervention for patients who develop restless leg syndrome symptoms after starting the medication, with full recovery occurring in all documented cases 1, 2

Treatment Approach

• The preferred approach for managing topiramate-induced restless leg syndrome is discontinuation of the medication, rather than adding a dopaminergic agonist, due to the risk of augmentation 1, 2